Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM1 for Prevention of Taxane-Induced Neurotoxicity in Breast Cancer
NCT02468739Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- May 2015
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of monosialotetrahexosylganglioside in taxane-induced peripheral neuropathy (TIPN), sponsored by Sun Yat-sen University. Started May 2015; status: completed.
02
Drugs
monosialotetrahexosylganglioside
03
Conditions
taxane-induced peripheral neuropathy (TIPN)
Beyond the preview
Go deeper on NCT02468739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468739.